Drug recall · September 1, 2021
Trulicity recall
Why: Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
- Lots / codes
Lot number: D396436C
- Quantity
- 119,539 4-packs
- Company
- Eli Lilly & Company, Indianapolis, IN
- Distribution
- USA Nationwide
- Initiated
- August 19, 2021 · Voluntary: Firm initiated
- Classified
- August 26, 2021
- Reported
- September 1, 2021
- Ended
- August 7, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trulicity
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.